Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Patients With Alcohol Dependence
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2017
Price : $35 *
At a glance
- Drugs BTRX 246040 (Primary)
- Indications Alcohol withdrawal
- Focus Proof of concept; Therapeutic Use
- Sponsors BlackThorn Therapeutics; Eli Lilly
- 05 Jun 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 25 Apr 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 24 Jan 2014 Planned End Date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.